The impact of barriers to hepatitis C virus treatment in recovering heroin users maintained on methadone

Journal of Substance Abuse Treatment

Volumn 29, Issue 3, 2005, Pages 159-165

  Sylvestre, Diana L ^a,b   Litwin, Alain H ^c   Clements, Barry J ^b   Gourevitch, Marc N ^d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Organization to Achieve Solutions in Substance Abuse (OASIS)   (United States)

^c ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^d NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Abstinence; Barrier; Drug use; Hepatitis C; Psychiatric disease

Indexed keywords

ALPHA2B INTERFERON; METHADONE; RIBAVIRIN;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DATA ANALYSIS; DISEASE ASSOCIATION; DRUG EFFICACY; DRUG SAFETY; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HEROIN DEPENDENCE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SIDE EFFECT; TREATMENT OUTCOME; VIROLOGY;

DELIVERY OF HEALTH CARE; FEMALE; HEPATITIS C; HEROIN DEPENDENCE; HUMANS; MALE; MENTAL DISORDERS; METHADONE; MIDDLE AGED;

EID: 25644435773     PISSN: 07405472     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jsat.2005.06.002     Document Type: Article

References (25)

1. M.J. Alter Epidemiology of hepatitis C Hepatology 26 3 Suppl 1 1997 62S 65S
2. M.J. Alter, and L.A. Moyer The importance of preventing hepatitis C virus infection among injection drug users in the United States Journal of Acquired Immune Deficiency Syndromes Human Retrovirology 18 Suppl 1 1998 S6 S10
3. M. Backmund, and K. Meyer Treatment of hepatitis C infection in injection drug users Hepatology 34 2001 188 193
4. L. Capuron, and C.L. Raison Association of exaggerated HPA axis response to the initial injection of interferon-alpha with development of depression during interferon-alpha therapy American Journal of Psychiatry 160 2003 1342 1345
5. O. Dalgard, and K. Bjoro Treatment of chronic hepatitis C in injecting drug users: 5 years' follow-up European Addiction Research 8 2002 45 49
6. G.L. Davis, and J.R. Rodrigue Treatment of chronic hepatitis C in active drug users New England Journal of Medicine 345 2001 215 217
7. B.R. Edlin Prevention and treatment of hepatitis C in injection drug users Hepatology 36 5 Suppl 1 2002 S210 S219
8. R.J. Fontana Neuropsychiatric toxicity of antiviral treatment in chronic hepatitis C Digestive Diseases 18 2000 107 116
9. S.B. Ho, and H. Nguyen Influence of psychiatric diagnoses on interferon-alpha treatment for chronic hepatitis C in a veteran population American Journal of Gastroenterology 96 2001 157 164
10. S. Jowett, and K. Agarwal Managing chronic hepatitis C acquired through intravenous drug use QJM 94 2001 153 158
11. D.M. Lerner, and A. Stoudemire Neuropsychiatric toxicity associated with cytokine therapies Psychosomatics 40 1999 428 435
12. J.G. McHutchison, and S.C. Gordon Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group New England Journal of Medicine 339 1998 1485 1492
13. J.G. McHutchison, and M. Manns Adherence to combination therapy enhances sustained response in genotype-1-infected patients with chronic hepatitis C Gastroenterology 123 2002 1061 1069
14. National Institutes of Health National Institutes of Health Consensus Development Conference Statement: Management of hepatitis C: 2002-June 10-12, 2002 Hepatology 36 5 Suppl 1 2002 S3 S20
15. C.M. Pariante, and M.G. Orru Treatment with interferon-alpha in patients with chronic hepatitis and mood or anxiety disorders Lancet 354 1999 131 132
16. S. Pianko, and J.G. McHutchison Treatment of hepatitis C with interferon and ribavirin Journal of Gastroenterology and Hepatology 15 2000 581 586
17. T. Poynard, and P. Marcellin Randomised trial of interferon alpha2b plus ribavirin for 48 weeks or for 24 weeks versus interferon alpha2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus. International Hepatitis Interventional Therapy Group (IHIT) Lancet 352 1998 1426 1432
18. C.L. Raison, and A.H. Miller The neuroimmunology of stress and depression Seminars in Clinical Neuropsychiatry 6 2001 277 294
19. D.A. Regier, and M.E. Farmer Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study Journal of the American Medical Association 264 1990 2511 2518
20. M. Schaefer, and F. Schmidt Adherence and mental side effects during hepatitis C treatment with interferon alfa and ribavirin in psychiatric risk groups Hepatology 37 2003 443 451
21. E.R. Schiff The alcoholic patient with hepatitis C virus infection American Journal of Medicine 107 1999 95S 99S
22. P.C. Trask, and P. Esper Psychiatric side effects of interferon therapy: Prevalence, proposed mechanisms, and future directions Journal of Clinical Oncology 18 2000 2316 2326
23. D.H. Van Thiel, and L. Friedlander Interferon-alpha can be used successfully in patients with hepatitis C virus-positive chronic hepatitis who have a psychiatric illness European Journal of Gastroenterology & Hepatology 7 1995 165 168
24. D.H. Van Thiel, and L. Friedlander Treatment of chronic hepatitis C in individuals with pre-existing or confounding neuropsychiatric disease Hepatogastroenterology 45 1998 328 330
25. D. Zdilar, and K. Franco-Bronson Hepatitis C, interferon alfa, and depression Hepatology 31 2000 1207 1211